Edited by Professor Boris Zhivotovsky Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
Borner, T
CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF- signaling
Sickle cell anaemia and malaria
Most capsule products land at 250-500 mcg per capsule, which is within this range, but no human dose-finding trial exists to confirm optimal dosing
So, why not give your body a boost with a little sunshine in a syringe